🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the maximal tolerated dose (MTD) ...
Status
Terminated
Location
Shanghai Proton and Heavy Ion Center
Start Date
2015-09
Trial ID
NCT02801487
Treatments Being Tested
Part A- The purpose of this study is to determine a safe dose of LY2801653 ...
Status
Completed
Location
Arizona Cancer Center
Start Date
2009-09-09
Trial ID
NCT01285037
Treatments Being Tested
The investigators aimed to evaluate the safety of weekly paclitaxel with on...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2014-12
Trial ID
NCT02344095
Treatments Being Tested
The purpose of the study is to evaluate the role of hypofractionated in the...
Status
Unknown
Location
David Cantu de Leon
Start Date
2017-11-10
Trial ID
NCT03750539
Treatments Being Tested
The study try to show the weekly cisplatin based CCRT is not inferior to 3-...
Status
Unknown
Location
Samsung Medical Center
Start Date
2009-11
Trial ID
NCT01171781
Treatments Being Tested
This Global Phase 3 study aims to find out whether RRx-001 + platinum chemo...
Status
Active Not Recruiting
Location
H. Lee Moffitt Cancer Center & Research Institute, Inc.
Start Date
2022-08-01
Trial ID
NCT05566041
Treatments Being Tested
Based on the Phase I trial completed by the sponsor, the Phase II clinical ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-06
Trial ID
NCT06426056
Treatments Being Tested
This study is designed to explore the potential of the epigenetic agent RRx...
Status
Completed
Location
Stanford University
Start Date
2015-06
Trial ID
NCT02489903
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Lineberger Comprehensive Cancer Center, UNC
Start Date
1997-03
Trial ID
NCT00002984
Treatments Being Tested
The objectives for this study is as follows: * Primary: * To evaluate t...
Status
Completed
Location
University of Pittsburgh Cancer Institute
Start Date
2007-11
Trial ID
NCT00798655
Treatments Being Tested